FDA Adverse Event Injury Summary report: N

MORPHEUS8

MDR report key: 19758676 · Received July 17, 2024

Report

Report Number
3010511300-2024-00567
Event Type
Injury
Date Received
July 17, 2024
Date of Event
June 8, 2024
Report Date
July 17, 2024
Manufacturer
INMODE LTD.
Product Code
GEI
UDI-DI
07290016633412
PMA / PMN Number
K200947
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CA
Reporter Occupation
117

Narratives

Additional Manufacturer Narrative · 0

TECHNICAL INSPECTION DID NOT REVEAL ANY ISSUES RELATED TO THE INCIDENT. INVESTIGATION ATTRIBUTED THE ROOT-CAUSE TO USER ERRORS AND ADDITIONAL HUMAN FACTORS: MORPHEUS8 TREATMENT WAS PERFORMED ON BLEEDING/BRUISED INJECTION SITES, WHEN THE OPERATOR SHOULD HAVE ABSTAINED FROM PERFORMING THE TREATMENT ONCE SEEING SUCH REACTION TO THE INJECTIONS. THE INJECTION OF THE ANESTHETIC SOLUTION APPARENTLY WAS DONE INCORRECTLY (TOO MUCH VOLUME, SITES TOO CLOSE TO ONE ANOTHER, POSSIBLE INCORRECT PREPARATION OF THE SOLUTION, E.G. INCORRECT CONCENTRATION OF EPINEPHRINE AND HENCE INCREASED BLEEDING). ADDITIONAL INTRINSIC FACTORS SUCH AS PATIENT'S COAGULATION PROBLEMS COULD HAVE CONTRIBUTED TO THE INCREASED BLEEDING. THE OPERATOR USED EXTREMELY AGGRESSIVE TREATMENT PARAMETERS FOR MORPHEUS8, NOT CONGRUENT WITH THE IFU, WHICH FURTHER CONTRIBUTED TO THE FORMATION OF THE LESIONS. IT SEEMS THERE WAS SOME ADDITIONAL MECHANICAL DAMAGE TO THE AREA POST TREATMENT (E.G. BY FRICTION WITH CLOTHES) AND SECONDARY INFECTION BROUGHT BY LACK OF ASEPTIC CONDITIONS POST TREATMENT.

Description of Event or Problem · 0

NECROTIC LESIONS AT INJECTION SITES OF ANESTHETIC SOLUTION FOLLOWING MORPHEUS8 TREATMENT

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
706321 MORPHEUS8 GEI GEI INMODE LTD. AG607401A 07290016633412

Patients

Seq Age Sex Outcome Treatment
1 53 YR Female Required Intervention